Results 251 to 260 of about 2,311,467 (287)
Some of the next articles are maybe not open access.
Prevention and Treatment of Respiratory Distress Syndrome in Preterm Neonates
Neonatal Network, 2018Respiratory distress syndrome (RDS) impacts a high proportion of preterm neonates, resulting in significant morbidity and mortality. Advances in pharmacotherapy, specifically antenatal corticosteroids and postnatal surfactant therapy, have significantly reduced the incidence and impact of neonatal RDS.
Christopher, McPherson +1 more
openaire +2 more sources
Mean platelet volume in neonatal respiratory distress syndrome
Pediatrics International, 2009AbstractThe aim of this study was to investigate the differences in mean platelet volume (MPV) between neonates with and without neonatal respiratory distress syndrome (RDS). Eighty‐three premature infants who were admitted to the neonatal intensive care unit were included in the study.
YİĞİT, ŞULE +3 more
openaire +3 more sources
The Fate of Exogenous Surfactant in Neonates with Respiratory Distress Syndrome
Clinical Pharmacokinetics, 1994Respiratory distress syndrome (RDS) in newborn neonates is characterised by deficient secretion of surfactant from type III alveolar cells. Administration of surfactant to airways acutely decreases the degree of respiratory failure and increases the survival rate in neonates with RDS.
M, Hallman, T A, Merritt, K, Bry
openaire +2 more sources
Reduced Platelet Counts in Neonatal Respiratory Distress Syndrome
Biology of the Neonate, 2009Platelet counts were studied in preterm infants with the respiratory distress syndrome (RDS), excluding patients with significant perinatal and postnatal hypoxia. Counts fell to a nadir on day 4 (p < 0.000). Exploratory analysis indicated that severity of RDS (levels of FiO<sub>2</sub> and mean airway pressure), airleak syndrome, grade ...
D, Kohelet +3 more
openaire +2 more sources
Surfactant therapy for neonatal respiratory distress syndrome in 2013
The Journal of Maternal-Fetal & Neonatal Medicine, 2013Surfactant whether given prophylactically in the delivery room or to babies with established respiratory distress syndrome (RDS) reduces the severity of RDS, incidence of air leaks and pneumothorax and, most importantly, neonatal death. Despite being the most intensively studied intervention in neonatal medicine, there is still debate among ...
David G, Sweet +2 more
openaire +2 more sources
Neonatal respiratory distress syndrome
The Lancet, 2006Sven, Montan, Sabaratnam, Arulkumaran
openaire +2 more sources
Surfactant for neonatal respiratory distress syndrome
Journal of Pediatric Health Care, 1990Rosalie Sagraves +2 more
openaire +2 more sources
Care of the neonate with respiratory distress syndrome
1989Respiratory distress in the newborn baby can be seen as a result of hypovolaemia, hypoglycaemia, congenital heart disease and cerebral haemorrhage. However, the term ‘respiratory distress syndrome’ is applied to a condition which is associated with the immature lungs of the preterm infant.
openaire +1 more source
Neonatal diagnosis of respiratory distress syndrome.
The European respiratory journal. Supplement, 1989After a brief historical recall, this review states the needs for an accurate diagnosis of the neonatal respiratory distress syndrome (RDS). The clinical features consist of disturbances of respiratory rate, grunting, intercostal retractions, and cyanosis, but early mechanical ventilation tends to suppress most of them.
H, Walti, M, Couchard, J P, Relier
openaire +1 more source
Surfactant replacement therapy for neonatal respiratory distress syndrome
The Indian Journal of Pediatrics, 1990Surfactant treatment of RDS improves oxygcnation and ventilation whether given immediately after birth or after the onset of the disease. There is also a decrease in associated morbidity (air leak), and improved survival with no significant short term side effects. Information about long term follow-up is limited, but encouraging.
openaire +2 more sources